Peijia Medical Limited

DB:4WO Stock Report

Market Cap: €322.0m

Peijia Medical Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Yi Zhang

Chief executive officer

CN¥1.5m

Total compensation

CEO salary percentage50.7%
CEO tenure12.6yrs
CEO ownership0.8%
Management average tenure5.2yrs
Board average tenure5yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Yi Zhang's remuneration changed compared to Peijia Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-CN¥252m

Mar 31 2024n/an/a

-CN¥322m

Dec 31 2023CN¥1mCN¥740k

-CN¥393m

Sep 30 2023n/an/a

-CN¥460m

Jun 30 2023n/an/a

-CN¥528m

Mar 31 2023n/an/a

-CN¥468m

Dec 31 2022CN¥1mCN¥1m

-CN¥408m

Sep 30 2022n/an/a

-CN¥449m

Jun 30 2022n/an/a

-CN¥491m

Mar 31 2022n/an/a

-CN¥533m

Dec 31 2021CN¥2mCN¥1m

-CN¥574m

Compensation vs Market: Yi's total compensation ($USD200.05K) is below average for companies of similar size in the German market ($USD1.01M).

Compensation vs Earnings: Yi's compensation has increased whilst the company is unprofitable.

CEO

Yi Zhang (56 yo)

12.6yrs

Tenure

CN¥1,460,000

Compensation

Dr. Yi Zhang has been an Executive Director of Peijia Medical Limited since May 30, 2012. He serves as the Chairman and Chief Executive Officer at Peijia Medical Limited and served as its Chief Technology...

Leadership Team

NamePositionTenureCompensationOwnership
Yi Zhang
Chairman & CEOno dataCN¥1.46m0.80%
€ 2.6m
Lieh Tsai
Chief Financial Officer5.7yrsno datano data
Kongrong Pan
Chief Operating Officer7.3yrsno datano data
Fong Tan Jian
Chief Technology Officer3.9yrsno datano data
Ping Ye Zhang
Executive Director4.9yrsCN¥182.00k0.16%
€ 502.9k
Hong Ye
Executive Director & Company Secretary12.2yrsCN¥1.36m2.09%
€ 6.7m
Xiaoxiao Zhuang
Vice President of Sales4.7yrsno datano data
Hongpeng Wang
Vice President of Marketing5.4yrsno datano data
Hing Ling Chau
Company Secretary2.5yrsno datano data

5.2yrs

Average Tenure

49yo

Average Age

Experienced Management: 4WO's management team is seasoned and experienced (5.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Yi Zhang
Chairman & CEO12.6yrsCN¥1.46m0.80%
€ 2.6m
Ping Ye Zhang
Executive Director6.3yrsCN¥182.00k0.16%
€ 502.9k
Hong Ye
Executive Director & Company Secretary12.2yrsCN¥1.36m2.09%
€ 6.7m
Stephen Newman Oesterle
Independent Non-Executive Director4.9yrsCN¥1.55mno data
Huacheng Wei
Independent Non-Executive Director3.3yrsCN¥315.00kno data
Wai Ming Yip
Independent Non-Executive Director4.9yrsCN¥314.00kno data
Fei Chen
Non-Executive Director5.5yrsno datano data
Robert Parks
Independent Non-Executive Director4.9yrsCN¥1.55mno data
Jifeng Guan
Non-Executive Director5.2yrsno datano data
Jun Yang
Non-Executive Director4.3yrsno datano data

5.0yrs

Average Tenure

56yo

Average Age

Experienced Board: 4WO's board of directors are considered experienced (5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 19:55
End of Day Share Price 2024/12/23 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Peijia Medical Limited is covered by 9 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sharon ShiBOCI Research Ltd.
Bo YuChina International Capital Corporation Limited
Yuan GaoChina International Capital Corporation Limited